Conquer Cancer Foundation of the American Society of Clinical Oncology meets the 20 Standards for Charity Accountability.
Established by the American Society of Clinical Oncology (ASCO), the Conquer Cancer Foundation supports clinical research, patient education, and patient advocacy programs that aim to benefit the world today and create new hope for the future. The organization funds initiatives spearheaded by the Foundation itself, by ASCO, and by program partners that work in the global campaign against cancer. The Foundation's focus extends from prevention through diagnosis, treatment, end-of-life care, and survivorship.
For the year ended December 31, 2016, Conquer Cancer Foundation of the American Society of Clinical Oncology's program expenses were:
Contributions to American Society of Clinical |
$11,641,675 |
Oncology grants and awards |
$10,843,460 |
Total Program Expenses: |
$22,485,135 |
-
Chief Executive
Nancy R. Daly, MS, MPH, Executive Vice President and Chief Philanthropic Officer
-
Compensation*
$350,079
-
Chair of the Board
Thomas Roberts
-
Chair's Profession / Business Affiliation
Managing Member and Portfolio Manager at Farallon Capital Management, LLC
-
Board Size
19
-
Paid Staff Size
38
*2016 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances. Note: In 2016, former CEOs, Dr. Allen S. Lichter and Dr. Clifford Hudis, received $600,905 and $371,341 in compensation, respectively.
Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Invitations to fund raising events, Membership appeals, Planned giving arrangements, Print advertisements (newspapers, magazines, etc.), Telephone appeals, Cause- related marketing (affinity credit cards, consumer product sales, etc.)
Fundraising costs were 21% of related contributions. (Related contributions, which totaled $20,169,784, are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c) (3) of the Internal Revenue Code.It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on Conquer Cancer Foundation of the American Society of Clinical Oncology's audited financial statements for the year ended December 31, 2016.
Source of Funds |
Contributions |
$20,169,784 |
ASCO reimbursement of fundraising costs |
$2,989,059 |
Investment income, net |
$1,559,868 |
Total Income |
$24,718,711 |
- Programs: 83%
- Fundraising: 16%
- Administrative: Less than 1%
Total Income |
$24,718,711 |
Program expenses |
$22,485,135 |
Fundraising expenses |
$4,314,097 |
Administrative expenses |
$291,843 |
Other expenses |
$0 |
Total expenses: |
$27,091,075 |
Income in Excess of Expenses |
$-2,372,364 |
Beginning Net Assets |
$57,891,825 |
Other Changes In Net Assets |
$0 |
Ending Net Assets |
$55,519,461 |
Total Liabilities |
$4,678,434 |
Total Assets |
$60,197,895 |